Bio-Techne And Nikon Instruments Inc. Announce Partnership To Expand Access To Innovative Spatial Biology Services
Portfolio Pulse from Benzinga Newsdesk
Bio-Techne Corporation (NASDAQ:TECH) and Nikon Instruments Inc. have announced a partnership to expand access to spatial biology services in the US. This collaboration involves Lunaphore, a part of Bio-Techne's Spatial Biology Division, and the Nikon BioImaging Lab. The partnership aims to leverage Lunaphore's COMET technology and Nikon's imaging solutions to enhance research and drug discovery. The COMET platform, known for its high-throughput, hyperplex protein detection capabilities, will be complemented by Lunaphore's HORIZON image analysis software, offering a comprehensive suite for spatial biology research.
March 28, 2024 | 1:09 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Bio-Techne's partnership with Nikon Instruments Inc. to expand spatial biology services in the US could enhance the company's visibility and market share in the biotech and pharmaceutical sectors. The collaboration, focusing on the COMET platform and HORIZON software, positions Bio-Techne at the forefront of spatial biology research, potentially driving increased demand for its services.
The partnership with Nikon Instruments Inc. directly involves Bio-Techne's spatial biology division and its flagship technologies, indicating a significant impact on the company's market position and product demand. The collaboration's focus on expanding access to innovative services in the US, a key market, suggests a positive outlook for Bio-Techne's business growth and customer base expansion.
CONFIDENCE 80
IMPORTANCE 85
RELEVANCE 90